Market data not licensed for redistribution.
Komipharm International
041960 · KOSDAQ · Pharmaceuticals Manufacturing
Close
Source: Financial Services Commission stock price data (data.go.kr), updated once a day.
Daily price, 1 year
Key statistics
Market cap (KRW bn)–
PER–
PBR–
ROE %-4.6
Debt ratio % (liabilities / equity)88
Revenue TTM (KRW bn)53.0
Op. profit TTM (KRW bn)1.8
Dividend yield %–
Basis: market cap at …; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.
Upcoming risk events
Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.
No scheduled risk events found (last checked 2026-10-30 19:40 KST).
Annual results (KRW bn)
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 35.8 | 39.8 | 42.6 | 58.8 | 52.5 |
| Operating profit | -5.3 | -3.8 | -6.3 | 6.2 | 2.0 |
| Net income | -5.9 | -7.5 | -5.9 | 14.7 | -8.0 |
Quarterly results (KRW bn, 3 months)
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | |
|---|---|---|---|---|---|---|
| Revenue | 14.4 | 13.7 | 12.5 | 11.9 | 11.9 | 16.7 |
| Operating profit | 0.5 | 1.6 | 0.1 | -0.2 | 0.3 | 1.6 |
| Net income | -0.1 | -3.3 | -0.3 | -4.3 | 0.7 | 0.5 |
Largest shareholder
As of the 2025 annual report: 양경훈 and related parties hold 38.36% of common shares.
Recent disclosures
| Date | Filing | Summary | |
|---|---|---|---|
| 2026-10-27 | Insider / major-holder ownership report 임원ㆍ주요주주특정증권등소유상황보고서 | DART original | |
| 2026-09-10 | Single sales/supply contract [기재정정]단일판매ㆍ공급계약체결 | DART original | |
| 2026-08-13 | Periodic report (annual/half/quarterly) 반기보고서 (2026.06) | DART original | |
| 2026-05-14 | Periodic report (annual/half/quarterly) 분기보고서 (2026.03) | DART original | |
| 2026-04-08 | Single sales/supply contract [기재정정]단일판매ㆍ공급계약체결 | DART original | |
| 2026-03-26 | Shareholder meeting 정기주주총회결과 | DART original | |
| 2026-03-26 | Governance / misc. (routine) 주식매수선택권부여에관한신고 | DART original | |
| 2026-03-18 | Audit report submission 감사보고서제출 | DART original | |
| 2026-03-18 | Periodic report (annual/half/quarterly) [첨부추가]사업보고서 (2025.12) | DART original | |
| 2026-03-11 | Shareholder meeting [기재정정]주주총회소집결의 | DART original | |
| 2026-03-11 | Revenue/profit change >=30% (15% large caps) [기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동 | DART original | |
| 2026-03-11 | Shareholder meeting 의결권대리행사권유참고서류 | DART original |
Past material filings and price reaction (market-adjusted)
| Date | Filing type | On the news (vs. market) | Next day (vs. market) | 20 days (vs. market) |
|---|---|---|---|---|
| 2026-02-20 | Revenue/profit change >=30% (15% large caps) | -1.1% | +4.7% | +3.9% |
| 2025-11-05 | Share buyback decision | +9.8% | -5.3% | +5.4% |
| 2025-10-14 | Single sales/supply contract | -2.1% | -2.5% | -6.2% |
| 2025-07-30 | Convertible bond issuance | +0.8% | +0.1% | +14.2% |
| 2025-06-20 | Share buyback decision | +4.0% | -1.8% | -1.2% |
| 2025-03-26 | Share buyback decision | +1.9% | +1.7% | +52.3% |
| 2025-02-19 | Revenue/profit change >=30% (15% large caps) | -0.4% | +0.9% | +3.9% |
| 2024-07-31 | Share buyback decision | -0.1% | -0.9% | +3.5% |
| 2024-05-29 | Share buyback decision | +1.5% | -0.1% | -0.0% |
| 2024-04-03 | Tangible asset / business transfer | +0.3% | -3.0% | -4.0% |
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view
Market data not licensed for redistribution.
© Crypvu · Crypto market view